STATE STREET CORP - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 36 filers reported holding LUMOS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$37,0820.0%11,2370.0%0.00%
Q2 2023$37,082
-2.7%
11,2370.0%0.00%
Q1 2023$38,093
-53.0%
11,237
-50.0%
0.00%
Q4 2022$81,132
-18.0%
22,474
+100.0%
0.00%
Q3 2022$99,000
+13.8%
11,2370.0%0.00%
Q2 2022$87,000
-17.9%
11,2370.0%0.00%
Q1 2022$106,000
+35.9%
11,2370.0%0.00%
Q4 2021$78,000
-27.1%
11,2370.0%0.00%
Q3 2021$107,000
-4.5%
11,2370.0%0.00%
Q2 2021$112,00011,2370.00%
Other shareholders
LUMOS PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Acuitas Investments, LLC 125,242$413,2990.24%
Lion Point Capital, LP 90,794$299,6200.13%
Greenwich Wealth Management LLC 76,341$2520.03%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 25,760$85,0080.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
Leucadia National 120,651$398,1480.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders